CalciMedica, Inc.: ARMISTICE CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Armistice Capital, LLC amended its Schedule 13G stake filing for CalciMedica, Inc., disclosing the change in a filing with the SEC under accession number 0001172661-26-005216. The amendment updates the investment firm's reported ownership position in the clinical-stage biopharmaceutical company. Schedule 13G filings are used by investors holding passive stakes of more than 5% in a public company, so the revision signals a change in Armistice's beneficial ownership. The exact size and direction of the stake change were not specified in the filing notice. Investors will watch for further 13G or 13D filings to gauge whether Armistice is building or trimming its position in CalciMedica.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
CalciMedica, Inc., Armistice Capital, LLC